Alnylam Pharmaceuticals shares owned by Capstone Investment Advisors
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Capstone Investment Advisors
from 13F filings
Historical chart of Capstone Investment Advisors investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Capstone Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $7.8M | 20k | 397.65 |
| 2025-09-30 | $561k | 1.2k | 456.00 |
| 2024-09-30 | $455k | 1.7k | 275.03 |
| 2022-09-30 | $881k | 4.4k | 200.23 |
| 2020-06-30 | $5.9M | 40k | 148.10 |
| 2020-03-31 | $4.4M | 40k | 108.85 |
| 2016-03-31 | $1.4M | 22k | 62.76 |
More positions owned by Capstone Investment Advisors
View all positions for Capstone Investment Advisors